Lantheus Holdings Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone. I'm Sanji Bita with JPMorgan Healthcare. And we are pleased to have with us the CEO of Lantheus, Mary Anne Heino. For logistic purposes, please reserve your questions till the end of the presentation. And with that, I will let Mary Anne take over.
Thank you. Good morning, everyone, and thank you so much for joining the Lantheus JPM presentation. As we start with the next slide, I will show you a slide that I'm sure you've seen in many other presentations. It is our policy around safe harbor statements and forward-looking information. It's available here as well as our website. So I'd appreciate if you would take a moment to look at it.
As we begin our presentation today, I'd like to share with you our vision for Lantheus, and our vision is that Lantheus will be -- is and will remain the leading radiopharmaceutical-focused company in the world. It's something that we think is very important, and it really serves our mission to find, fight and follow disease
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
